High pressure liquid chromatographic quantitation of teicoplanin in human serum. 1987

J Levy, and B L Truong, and H Goignau, and Y Van Laethem, and J P Butzler, and P Bourdoux

A reverse phase high-pressure liquid chromatographic method to assay teicoplanin in serum is described. The procedure involves a single protein precipitation step with acetonitrile containing the internal standard mephenesin, followed by direct injection of the supernatant into the chromatograph. This HPLC method has good linearity, precision, recovery and sensitivity over the range of serum concentrations observed with the recommended dosages of the drug (5-50 mg/l). The assay has been validated by a correlation study with a bioassay on 97 sera obtained from patients treated with teicoplanin (r = 0.9519, P less than 0.001). The small serum sample size (100 microliters) and the use of a common C18 column make this assay ideal for drug monitoring, provided that HPLC equipment is available.

UI MeSH Term Description Entries
D007202 Indicators and Reagents Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant & Hackh's Chemical Dictionary, 5th ed, p301, p499) Indicator,Reagent,Reagents,Indicators,Reagents and Indicators
D007700 Kinetics The rate dynamics in chemical or physical systems.
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D006020 Glycopeptides Proteins which contain carbohydrate groups attached covalently to the polypeptide chain. The protein moiety is the predominant group with the carbohydrate making up only a small percentage of the total weight. Glycopeptide
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D017334 Teicoplanin Lipoglycopeptide antibiotic from Actinoplanes teichomyceticus active against gram-positive bacteria. It consists of five major components each with a different fatty acid moiety. Teichomycin,Targocid,Teichomycin A2

Related Publications

J Levy, and B L Truong, and H Goignau, and Y Van Laethem, and J P Butzler, and P Bourdoux
November 1983, Antimicrobial agents and chemotherapy,
J Levy, and B L Truong, and H Goignau, and Y Van Laethem, and J P Butzler, and P Bourdoux
March 1978, Journal of pharmaceutical sciences,
J Levy, and B L Truong, and H Goignau, and Y Van Laethem, and J P Butzler, and P Bourdoux
January 1978, The Journal of laboratory and clinical medicine,
J Levy, and B L Truong, and H Goignau, and Y Van Laethem, and J P Butzler, and P Bourdoux
August 1987, Antimicrobial agents and chemotherapy,
J Levy, and B L Truong, and H Goignau, and Y Van Laethem, and J P Butzler, and P Bourdoux
June 1993, Clinical biochemistry,
J Levy, and B L Truong, and H Goignau, and Y Van Laethem, and J P Butzler, and P Bourdoux
January 1983, Reviews of infectious diseases,
J Levy, and B L Truong, and H Goignau, and Y Van Laethem, and J P Butzler, and P Bourdoux
July 1976, Analytical chemistry,
J Levy, and B L Truong, and H Goignau, and Y Van Laethem, and J P Butzler, and P Bourdoux
May 1984, Antimicrobial agents and chemotherapy,
J Levy, and B L Truong, and H Goignau, and Y Van Laethem, and J P Butzler, and P Bourdoux
October 1976, Journal of pharmaceutical sciences,
J Levy, and B L Truong, and H Goignau, and Y Van Laethem, and J P Butzler, and P Bourdoux
February 1989, Journal of pharmaceutical sciences,
Copied contents to your clipboard!